AMAM insider filings

Ambrx Biopharma, Inc. — 38 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-03-07. Screen AMAM transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for AMAM between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Ambrx Biopharma, Inc.

FiledFormInsiderReported transactionsSource
2024-03-074Aromando Andrew — Chief Operating OfficerDisposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 371,428 (derivative) · Disposition to issuer (D): 55,570 (derivative)EDGAR
2024-03-074Loesberg Janet — DirectorDisposition to issuer (D): 12,142 (derivative) · Disposition to issuer (D): 30,000 (derivative) · Disposition to issuer (D): 15,000 (derivative)EDGAR
2024-03-074Hermans Kate — DirectorDisposition to issuer (D): 12,142 (derivative) · Disposition to issuer (D): 30,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 30,000 (derivative)EDGAR
2024-03-074Nelson Sonja — Chief Financial OfficerDisposition to issuer (D): 22,936 · Disposition to issuer (D): 107,143 (derivative) · Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 367,799 (derivative) · Disposition to issuer (D): 121,427 (derivative) · Disposition to issuer (D): 60,714 (derivative) · +1 moreEDGAR
2024-03-074O'Connor Daniel J. — President and CEO, DirectorDisposition to issuer (D): 48,202 · Disposition to issuer (D): 294,643 (derivative) · Disposition to issuer (D): 750,000 (derivative) · Disposition to issuer (D): 772,857 (derivative) · Disposition to issuer (D): 173,785 (derivative)EDGAR
2024-03-074Glover Stephen C. — DirectorDisposition to issuer (D): 12,142 (derivative) · Disposition to issuer (D): 30,000 (derivative) · Disposition to issuer (D): 2,500 (derivative) · Disposition to issuer (D): 5,714 (derivative)EDGAR
2024-03-074DALESANDRO MARGARET — DirectorDisposition to issuer (D): 17,857 (derivative) · Disposition to issuer (D): 10,119 (derivative)EDGAR
2024-03-074MAIER PAUL V — DirectorDisposition to issuer (D): 12,142 (derivative) · Disposition to issuer (D): 30,000 (derivative) · Disposition to issuer (D): 15,000 (derivative)EDGAR
2023-12-114Aromando Andrew — Chief Operating OfficerGrant/award (A): 100,000 @ $0EDGAR
2023-12-114Nelson Sonja — Chief Financial OfficerGrant/award (A): 50,000 @ $0EDGAR
2023-12-114O'Connor Daniel J. — President and CEO, DirectorGrant/award (A): 750,000 @ $0EDGAR
2023-10-314Nelson Sonja — Chief Financial OfficerSale (S): 12,778 @ $9.82EDGAR
2023-10-314O'Connor Daniel J. — President and CEO, DirectorSale (S): 50,012 @ $9.82EDGAR
2023-10-254Cormorant Asset Management, LP — 10% owner
Chen Bihua — 10% owner
Cormorant Global Healthcare Master Fund, LP — 10% owner
Cormorant Private Healthcare Fund III LP — 10% owner
Purchase (P): 1,307,311 @ $6.99EDGAR
2023-09-194Cormorant Asset Management, LP — 10% owner
Chen Bihua — 10% owner
Cormorant Global Healthcare Master Fund, LP — 10% owner
Cormorant Private Healthcare Fund III LP — 10% owner
Purchase (P): 1,401,505 @ $9.05 · Purchase (P): 751,233 @ $9.24EDGAR
2023-09-064DALESANDRO MARGARET — DirectorGrant/award (A): 125,000 @ $0 · Grant/award (A): 70,833 @ $0EDGAR
2023-07-074Aromando Andrew — Chief Operating OfficerGrant/award (A): 389,000 (derivative) @ $0EDGAR
2023-07-074Nelson Sonja — Chief Financial OfficerGrant/award (A): 389,000 (derivative) @ $0EDGAR
2023-07-074O'Connor Daniel J. — President and CEO, DirectorGrant/award (A): 1,216,500 (derivative) @ $0EDGAR
2023-06-284Darwin Global Management, Ltd. — 10% owner
Darwin Global Master Fund, Ltd. — 10% owner
Trehan Abhishek — 10% owner
Purchase (P): 5,384,063 (derivative) @ $13.93EDGAR
2023-06-094Chang Xiaowei — DirectorGrant/award (A): 85,000 (derivative) @ $0 · Grant/award (A): 125,000 (derivative) @ $0EDGAR
2023-06-094Loesberg Janet — DirectorGrant/award (A): 85,000 @ $0EDGAR
2023-06-094Hermans Kate — DirectorGrant/award (A): 85,000 @ $0EDGAR
2023-06-094Glover Stephen C. — DirectorGrant/award (A): 85,000 @ $0 · Grant/award (A): 40,000 (derivative) @ $0 · Grant/award (A): 17,500 (derivative) @ $0EDGAR
2023-06-094MAIER PAUL V — DirectorGrant/award (A): 85,000 @ $0EDGAR
2023-05-264Glover Stephen C. — DirectorGrant/award (A): 210,000 (derivative) @ $0EDGAR
2023-05-054Aromando Andrew — Chief Operating OfficerGrant/award (A): 2,600,000 (derivative) @ $0EDGAR
2023-04-284Nelson Sonja — Chief Fin. & Operating OfficerGrant/award (A): 1,000,000 @ $0EDGAR
2023-04-284O'Connor Daniel J. — President and CEO, DirectorGrant/award (A): 2,750,000 @ $0EDGAR
2023-04-204Cormorant Asset Management, LP — 10% owner
Chen Bihua — 10% owner
Cormorant Global Healthcare Master Fund, LP — 10% owner
Cormorant Private Healthcare Fund III LP — 10% owner
Purchase (P): 3,376,646 @ $11.27 · Purchase (P): 951,909 @ $11.15 · Purchase (P): 886,634 @ $11.60EDGAR
2023-04-174Cormorant Asset Management, LP — 10% owner
Chen Bihua — 10% owner
Cormorant Global Healthcare Master Fund, LP — 10% owner
Cormorant Private Healthcare Fund III LP — 10% owner
Purchase (P): 1,193,808 @ $9.16 · Purchase (P): 841,967 @ $9.96 · Purchase (P): 562,121 @ $10.67EDGAR
2023-03-164Cormorant Asset Management, LP — 10% owner
Chen Bihua — 10% owner
Cormorant Global Healthcare Master Fund, LP — 10% owner
Cormorant Private Healthcare Fund III LP — 10% owner
Purchase (P): 250,000 @ $9.95 · Purchase (P): 250,000 @ $10.60 · Purchase (P): 500,000 @ $10.15EDGAR
2023-03-084Darwin Global Management, Ltd. — 10% ownerPurchase (P): 65,127 (derivative) @ $5.48 · Purchase (P): 39,957 (derivative) @ $6.02 · Purchase (P): 3,615,000 (derivative) @ $6.50EDGAR
2023-01-314Rupalla Katrin — DirectorDisposition to issuer (D): 200,000 (derivative) · Grant/award (A): 200,000 (derivative) · Disposition to issuer (D): 105,000 (derivative) · Grant/award (A): 105,000 (derivative)EDGAR
2023-01-314Loesberg Janet — DirectorDisposition to issuer (D): 210,000 (derivative) · Grant/award (A): 210,000 (derivative) · Disposition to issuer (D): 105,000 (derivative) · Grant/award (A): 105,000 (derivative)EDGAR
2023-01-314Hermans Kate — DirectorDisposition to issuer (D): 210,000 (derivative) · Grant/award (A): 210,000 (derivative) · Disposition to issuer (D): 105,000 (derivative) · Grant/award (A): 105,000 (derivative) · Disposition to issuer (D): 210,000 (derivative) · Grant/award (A): 210,000 (derivative)EDGAR
2023-01-314Nelson Sonja — Chief Fin. & Operating OfficerDisposition to issuer (D): 2,574,596 (derivative) · Grant/award (A): 2,574,596 (derivative) · Disposition to issuer (D): 850,000 (derivative) · Grant/award (A): 850,000 (derivative) · Disposition to issuer (D): 425,000 (derivative) · Grant/award (A): 425,000 (derivative)EDGAR
2023-01-314MAIER PAUL V — DirectorDisposition to issuer (D): 210,000 (derivative) · Grant/award (A): 210,000 (derivative) · Disposition to issuer (D): 105,000 (derivative) · Grant/award (A): 105,000 (derivative)EDGAR

Recent 8-K events — Ambrx Biopharma, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2024-03-128-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2024-03-078-K1.02 — Termination of a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2024-03-068-K5.07 — Submission of Matters to a Vote of Security Holders
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2024-02-228-K8.01 — Other EventsEDGAR
2024-01-088-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-12-018-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2023-10-238-K8.01 — Other EventsEDGAR
2023-10-168-K8.01 — Other EventsEDGAR
2023-10-128-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-10-108-K5.07 — Submission of Matters to a Vote of Security Holders
8.01 — Other Events
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=AMAM returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs